Haematopoietic stem cell transplantation in South Africa: Current limitations and future perspectives
Open Access
- 10 September 2019
- journal article
- review article
- Published by South African Medical Association NPC in South African Medical Journal
- Vol. 109 (8b) , 46-52
Abstract
The growing need for haematopoietic stem cell transplantation (HSCT) is reflected in the increasing number of transplants performed globally each year. HSCT provides life-changing and potentially curative therapy for a range of pathologies including haematological malignancies; other indications include certain congenital and acquired disorders of the haematopoietic system, autoimmune conditions and hereditary diseases. The primary goals of HSCT are either to replace haematopoietic stem and progenitor cells (HSPC) following myeloablative chemotherapy or to cure the original pathology with allogeneic HSPCs. Success depends on optimal outcomes at various stages of the procedure including mobilisation of marrow stem/progenitor cells for harvesting from the patient or donor, long-term and sustainable engraftment of these cells in the recipient, and prevention of graft-versus-host disease in the case of allogeneic HSCT. Challenges in South Africa include high cost, limited infrastructure and lack of appropriately trained staff, as well as limitations in securing suitable haematopoietic stem cell donors. This review aims to provide an overview of HSCT and some of the challenges that are faced in the South African context.Keywords
This publication has 52 references indexed in Scilit:
- Incidence of haematological malignancies, Eastern Cape Province; South Africa, 2004–2013Cancer Epidemiology, 2018
- Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic MalignanciesTransplantation and Cellular Therapy, 2016
- Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016Annals of Hematology, 2016
- Hematologic malignancies in South Africa 2000–2006: analysis of data reported to the National Cancer RegistryCancer Medicine, 2016
- Cyclophosphamide‐based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myelomaJournal of Clinical Apheresis, 2014
- Pre infusion, post thaw CD34+ peripheral blood stem cell enumeration as a predictor of haematopoietic engraftment in autologous haematopoietic cell transplantationTransfusion and Apheresis Science, 2014
- Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric PatientsTransplantation and Cellular Therapy, 2014
- Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center StudyTransplantation and Cellular Therapy, 2011
- Hematopoietic stem cell: self‐renewal versus differentiationWIREs Mechanisms of Disease, 2010
- Impending Challenges in the Hematopoietic Stem Cell Transplantation Physician WorkforceTransplantation and Cellular Therapy, 2009